Meet the team grid

Mr. Carstensen has worked in various executive capacities in the petroleum industry, as well as the
airline business until starting his own international business consultancy in 1999 specialising in
business structuring, banking advisory, asset protection, as well as community oriented not-for-profit
structures. Mr. Carstensen has lectured extensively throughout Australasia, Asia and Central America
on each of these subjects. While his educational background has been in accounting and finance, Mr.
Carstensen has always been a strong advocate for the health and wellness industry and is excited to be part of this new generation of healthcare.

A quick review of patents awarded to Dr. Shangjin Yang (see Appendix A) demonstrates expertise in optimising chemical synthesis processes for a wide range of molecules, coupled with medicinal drug development including successful cancer treatment drugs.
Dr. Yang's patent for optimised CBD production methods was filed September 11 2019.

Mr. Bowden's patent for new cannabinoids documents a project exploring hundreds of analogous modifications to THC resulting in compounds with up to 1,000 times the specific receptivity at CB1 receptor.

This translates roughly to drug potency. These compounds are poised for exploration as future medicines.Mr. Bowden is expecting to file new patents for new cannabinoids for treatment of pain, a use patent for novel cannabinoid analogues for treatment of cancer, and a specific patent for natural cannabis extract for treatment of skin cancer in Thailand

He has key high-profile contacts at all levels of the pharmaceutical industry across Europe and will quickly build the business from a position of vast experience and personal connections.